| Stereochemistry | ACHIRAL |
| Molecular Formula | C6H14N.Li |
| Molecular Weight | 107.123 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Li+].CC(C)[N-]C(C)C
InChI
InChIKey=ZCSHNCUQKCANBX-UHFFFAOYSA-N
InChI=1S/C6H14N.Li/c1-5(2)7-6(3)4;/h5-6H,1-4H3;/q-1;+1
| Molecular Formula | C6H15N |
| Molecular Weight | 101.19 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Li |
| Molecular Weight | 6.941 |
| Charge | 1 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Lithium diisopropylamide (LDA) is a prominent reagent used in organic synthesis. It is strong, low-nucleophilic base for e.g. enolisations. Corrosive to the eyes (may cause blindness), skin, mucous membranes and upper respiratory tract. Inhalation of vapors may cause dizziness, nausea, anesthesia, numbness, motor weakness in fingers and toes, incoordination, and headache.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|